Successful administration of ipilimumab to two kidney transplantation patients with metastatic melanoma

J Clin Oncol. 2014 Jul 1;32(19):e69-71. doi: 10.1200/JCO.2013.49.2314. Epub 2014 Feb 3.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Oral
  • Aged
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Dacarbazine / administration & dosage
  • Dacarbazine / analogs & derivatives
  • Drug Administration Schedule
  • Fluorodeoxyglucose F18 / metabolism
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Ipilimumab
  • Kidney Transplantation*
  • Lung Neoplasms / diagnosis
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / secondary
  • Lymph Nodes / pathology*
  • Lymphatic Metastasis / diagnosis
  • Male
  • Melanoma / diagnosis
  • Melanoma / drug therapy*
  • Melanoma / secondary
  • Middle Aged
  • Mycophenolic Acid / administration & dosage
  • Mycophenolic Acid / analogs & derivatives
  • Platinum Compounds / administration & dosage
  • Positron-Emission Tomography / methods
  • Prednisone / administration & dosage
  • Radiopharmaceuticals / metabolism
  • Skin Neoplasms / diagnosis
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Tacrolimus / administration & dosage
  • Temozolomide
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Immunosuppressive Agents
  • Ipilimumab
  • Platinum Compounds
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • Dacarbazine
  • Mycophenolic Acid
  • Prednisone
  • Tacrolimus
  • Temozolomide